Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record.

NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS

OVERGAARD, K., RIIS, B. J., CHRISTIANSEN, C., PØADENPHANT, J., JOHANSEN, J. S.·1989·Clinical Endocrinology

Abstract

SUMMARY: Thirty‐seven women with established osteoporosis completed a one‐year double‐blind, placebo‐controlled study with the primary aim of examining the effect of nasal salmon calcitonin (200 IU daily) on bone and calcium metabolism. All the women received a daily calcium supplement of 500 mg. For comparison we also report data from an age‐matched group of healthy women who did not receive calcium supplementation. The bone mineral measured in the forearm (single photon absorptiometry) and spine (dual photon absorptiometry) showed a similar pattern during treatment. The calcitonin group (n = 17) did not lose bone mineral in comparison with the placebo (n= 20) and the control groups (n= 19) (P< 0.01). The biochemical estimates of both bone resorption and bone formation decreased highly significantly in the calcitonin group (P< 0.001) and were unchanged in the control group, whereas the placebo (calcium) group showed intermediate values. Neither subjective nor objective side‐effects occurred in any of the groups. We conclude that nasal calcitonin is a realistic treatment of established osteoporosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1989.tb00443.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
OVERGAARD, K., RIIS, B. J., CHRISTIANSEN, C., PØADENPHANT, J., & JOHANSEN, J. S.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1989-04
Volume
30
Issue
4
Pages
435-442
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1967846975
Cited by
169
References
0
FWCI
20.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS. https://app.cochat.ai/papers/10.1111/j.1365-2265.1989.tb00443.x
The paper
OVERGAARD, K., RIIS, B. J., CHRISTIANSEN, C., PØADENPHANT, J., & JOHANSEN, J. S. (1989). NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1989.tb00443.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.